Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Rafia Bhore
- Frank Gerhard Holz (ORCID: https://orcid.org/0000-0001-8019-9272)
- Sérgio Leal (ORCID: https://orcid.org/0000-0001-7870-0478)
- Min Zhao (ORCID: https://orcid.org/0000-0002-4551-043X)
- Paolo Lanzetta (ORCID: https://orcid.org/0000-0003-3746-141X)
- David Eichenbaum (ORCID: https://orcid.org/0000-0003-0654-0668)
- Karen Chu (ORCID: https://orcid.org/0000-0001-7570-6970)
- Peter Morgan-Warren
- Robert Vitti
- Zoran Hasanbasic (ORCID: https://orcid.org/0000-0003-0673-012X)
- Ursula Schmidt-Ott
- Andrea Schulze
- Tien Yin Wong (ORCID: https://orcid.org/0000-0002-8448-1264)
- Alyson J. Berliner
- Boaz Hirshberg (ORCID: https://orcid.org/0000-0003-2829-3602)
- Kimberly Reed
- Yenchieh Cheng
- George D. Yancopoulos
- Thomas Schmelter (ORCID: https://orcid.org/0000-0003-1358-3172)
- William L Clark
- Xin Zhang (ORCID: https://orcid.org/0000-0001-5008-0879)
- Xiaodong Sun (ORCID: https://orcid.org/0000-0001-8439-9925)
- Zhanying Bai
- Tomohiro Iida
- Jean-François Korobelnik
Institutions
- University of Bonn (DE)
- Université de Bordeaux (FR)
- Inserm (FR)
- Regeneron (United States) (US)
- Singapore National Eye Center (SG)
- University Hospital Bonn (DE)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Palmetto Retina Center (US)
- Bordeaux Population Health (FR)
- Bayer (Switzerland) (CH)
- Istituto Europeo di Microchirurgia Oculare (IT)
- Shanghai First People's Hospital (CN)
- Tokyo Women's Medical University (JP)
- Bayer (China) (CN)
- Retina Vitreous Associates of Florida (US)
- Bayer (Germany) (DE)
Publication Details
- Journal
- Ophthalmology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1016/j.ophtha.2025.08.022
- Citations
- 4
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.83